Get the Stockscreener App
4.20
4.74%
0.19
Arbutus Biopharma Corp stock is traded at $4.20, with a volume of 2.83M.
It is up +4.74% in the last 24 hours and up +23.17% over the past month.
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
See More
Previous Close:
$4.01
Open:
$4
24h Volume:
2.83M
Relative Volume:
3.38
Market Cap:
$805.13M
Revenue:
$12.99M
Net Income/Loss:
$-74.39M
P/E Ratio:
-9.5455
EPS:
-0.44
Net Cash Flow:
$-78.92M
1W Performance:
+13.21%
1M Performance:
+23.17%
6M Performance:
+21.39%
1Y Performance:
-6.87%
1-Day Range:
$4.00
$4.37
1-Week Range:
$3.66
$4.37
52-Week Range:
$2.705
$4.725
Arbutus Biopharma Corp Stock (ABUS) Company Profile
Name
Arbutus Biopharma Corp
Sector
Industry
Phone
604-419-3200
Address
701 VETERANS CIRCLE, WARMINSTER, PA
Compare ABUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABUS
Arbutus Biopharma Corp
|
4.20 | 768.71M | 12.99M | -74.39M | -78.92M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-02-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-25-21 | Initiated | Jefferies | Hold |
| Dec-17-20 | Initiated | H.C. Wainwright | Buy |
| Jul-27-20 | Resumed | JMP Securities | Mkt Outperform |
| Jul-24-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-19-20 | Upgrade | Wedbush | Neutral → Outperform |
| Mar-06-20 | Upgrade | Chardan Capital Markets | Neutral → Buy |
| Feb-20-20 | Initiated | Robert W. Baird | Outperform |
| Feb-05-20 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Oct-07-19 | Reiterated | B. Riley FBR | Buy |
| Oct-04-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Oct-16-18 | Upgrade | B. Riley FBR | Neutral → Buy |
| Oct-15-18 | Upgrade | Wedbush | Underperform → Neutral |
| Oct-12-18 | Reiterated | Chardan Capital Markets | Buy |
| Jul-06-18 | Downgrade | B. Riley FBR, Inc. | Buy → Neutral |
| Mar-19-18 | Resumed | Chardan Capital Markets | Buy |
| Mar-19-18 | Downgrade | Wedbush | Outperform → Neutral |
| Jan-05-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Apr-04-17 | Upgrade | Chardan Capital Markets | Neutral → Buy |
| Feb-01-17 | Reiterated | Wedbush | Outperform |
| Dec-13-16 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Nov-30-16 | Upgrade | Chardan Capital Markets | Neutral → Buy |
View All
Arbutus Biopharma Corp Stock (ABUS) Latest News
exit strategy if you’re trapped in arbutus biopharma corporationIPO Watch & Long-Term Capital Growth Strategies - Newser
Arbutus Biopharma Corporation stock daily chart insightsPortfolio Update Summary & Real-Time Chart Pattern Alerts - Newser
Volume spikes in Arbutus Biopharma Corporation stock – what they meanJuly 2025 Closing Moves & AI Powered Buy/Sell Recommendations - Newser
Can a trend reversal in Arbutus Biopharma Corporation lead to recoveryQuarterly Risk Review & Free Weekly Watchlist of Top Performers - Newser
Chart based analysis of Arbutus Biopharma Corporation trendsQuarterly Market Summary & Expert Approved Momentum Ideas - Newser
How is Arbutus Biopharma Corporation managing supply chain issuesQuarterly Performance Summary & Stepwise Entry and Exit Trade Signals - خودرو بانک
Arbutus Biopharma Corporation stock outlook for YEARBond Market & Safe Entry Point Alerts - Newser
Using AI based signals to follow Arbutus Biopharma CorporationJuly 2025 Weekly Recap & Stock Portfolio Risk Control - Newser
What MACD and RSI say about Arbutus Biopharma CorporationEarnings Summary Report & Weekly Stock Performance Updates - Newser
Custom watchlist performance reports with Arbutus Biopharma CorporationQuarterly Market Summary & Real-Time Volume Analysis Alerts - Newser
How to read the order book for Arbutus Biopharma CorporationQuarterly Profit Report & AI Driven Price Forecasts - Newser
Can Arbutus Biopharma Corporation benefit from deglobalizationJuly 2025 Analyst Calls & Reliable Intraday Trade Plans - khodrobank.com
Using data models to predict Arbutus Biopharma Corporation stock movementLong Setup & Safe Capital Growth Stock Tips - Newser
Does Arbutus Biopharma Corporation qualify in momentum factor screening2025 Market Overview & Weekly High Return Opportunities - Newser
Multi asset correlation models including Arbutus Biopharma Corporation2025 Analyst Calls & Technical Pattern Alert System - Newser
Can swing trading help recover from Arbutus Biopharma Corporation losses2025 Growth vs Value & Weekly Market Pulse Updates - Newser
Using flow based indicators on Arbutus Biopharma CorporationWeekly Market Summary & Reliable Intraday Trade Alerts - Newser
Real time scanner hits for Arbutus Biopharma Corporation explainedWeekly Earnings Recap & Low Risk High Reward Ideas - Newser
Technical signs of recovery in Arbutus Biopharma CorporationQuarterly Investment Review & Real-Time Volume Spike Alerts - Newser
Is Arbutus Biopharma Corporation stock entering bullish territoryMarket Volume Summary & Free AI Powered Buy and Sell Recommendations - Newser
Real time pattern detection on Arbutus Biopharma Corporation stockMarket Volume Report & Weekly High Momentum Picks - Newser
Will Arbutus Biopharma Corporation outperform the marketJuly 2025 Intraday Action & Fast Gain Stock Tips - Newser
Should value investors consider Arbutus Biopharma CorporationEarnings Risk Report & Expert Verified Stock Movement Alerts - خودرو بانک
Analyzing recovery setups for Arbutus Biopharma Corporation investorsRate Cut & Free Weekly Watchlist of Top Performers - Newser
Is Arbutus Biopharma Corporation vulnerable to short sellersMarket Movement Recap & Daily Profit Maximizing Tips - خودرو بانک
Published on: 2025-09-03 05:15:59 - Newser
Tools to monitor Arbutus Biopharma Corporation recovery probability2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser
Can Arbutus Biopharma Corporation sustain earnings growth2025 Growth vs Value & Trade Opportunity Analysis - خودرو بانک
Arbutus Biopharma Corporation’s volatility index tracking explained2025 Performance Recap & Risk Managed Trade Strategies - Newser
Is Arbutus Biopharma Corporation trending in predictive chart modelsJuly 2025 Summary & Daily Stock Trend Reports - Newser
What are Arbutus Biopharma Corporation’s technical support levelsJuly 2025 Highlights & Long-Term Capital Growth Strategies - khodrobank.com
Nuveen LLC Invests $1.09 Million in Arbutus Biopharma Corporation $ABUS - Defense World
Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year? - sharewise.com
Is Arbutus Biopharma Corporation undervalued by DCF analysisMarket Growth Report & Reliable Price Breakout Signals - khodrobank.com
How to build a custom watchlist for Arbutus Biopharma CorporationJuly 2025 Review & Free Technical Pattern Based Buy Signals - Newser
Analyst Upgrade: How is Arbutus Biopharma Corporation managing supply chain issuesWeekly Profit Recap & Free Community Supported Trade Ideas - khodrobank.com
Is Arbutus Biopharma Corporation likely to announce a buybackLayoff News & Smart Swing Trading Alerts - khodrobank.com
Is Arbutus Biopharma Corporation on track to beat earningsJuly 2025 Technicals & Fast Entry and Exit Trade Plans - خودرو بانک
Technical analysis overview for Arbutus Biopharma Corporation stock - Newser
Measuring Arbutus Biopharma Corporation’s beta against major indicesPrice Action & Weekly Market Pulse Alerts - Newser
Published on: 2025-08-30 22:10:35 - Newser
Applying sector rotation models to Arbutus Biopharma CorporationWeekly Trend Recap & Technical Confirmation Alerts - Newser
Developing predictive dashboards with Arbutus Biopharma Corporation dataMarket Sentiment Summary & Accurate Buy Signal Alerts - Newser
Arbutus Biopharma Corp Stock (ABUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):